サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463658

アジア太平洋地域の脳脊髄液管理：2030年までの市場予測 - 地域分析 - 製品別、エンドユーザー別

Asia Pacific Cerebrospinal Fluid Management Market Forecast to 2030 - Regional Analysis - by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

出版日
ページ情報
英文 82 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.89円
アジア太平洋地域の脳脊髄液管理：2030年までの市場予測 - 地域分析 - 製品別、エンドユーザー別
出版日: 2024年01月19日
発行: The Insight Partners
ページ情報: 英文 82 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋地域の脳脊髄液管理市場は、2022年に3億8,953万米ドルと評価され、2030年には6億1,354万米ドルに達すると予測され、2022年から2030年までのCAGRは5.8%で成長すると予測されています。

神経疾患治療における髄液管理への注目の高まりがアジア太平洋地域の脳脊髄液管理市場を後押し

CSFパラメータは、成人患者における神経疾患のバイオマーカーとして広く評価されています。CSF中の循環マイクロRNAは、さまざまな神経疾患の診断に有望なバイオマーカーです。パーキンソン病（PD）、アルツハイマー病（AD）、てんかん、けいれんなどの神経疾患では、しばしばCSFパラメータが変化します。Nature』誌に掲載された論文によると、PDと診断された患者では、76種類の髄液蛋白質が正常な人と比べて構造的に変化していることが判明しました。この研究はまた、これらのCSFタンパク質が疾患の診断や治療のためのバイオマーカーとして使用できることを示唆しています。PDは、認知障害と運動機能の低下を伴う神経変性疾患です。2022年に発表された世界保健機関（WHO）の報告書によると、PDの有病率は過去25年間で倍増し、60歳以上の世界人口の約1％が罹患しています。同様に、発作やてんかんの状態にある患者では、タンパク質や乳酸値のような髄液パラメータのいくつかが変化します。そのため、発作やてんかんの治療に髄液パラメーターを使用するために、さまざまな研究開発が行われています。さらに、CSFを用いたアルツハイマー病検出のためのさまざまなCSFアッセイが市場に出回っているにもかかわらず、検出および治療目的のバイオマーカーに対するニーズは満たされていないです。アルツハイマー病やPDの症例検出が増加するにつれて、髄液漏れの症例が増加する可能性があるため、髄液管理デバイスの需要が増加しています。したがって、神経疾患の有病率の増加が、これらの疾患の治療に髄液管理製品を使用するための研究開発活動に拍車をかけています。

アジア太平洋地域の脳脊髄液管理市場の概要

アジア太平洋地域の脳脊髄液管理は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。アジア太平洋地域は、脳脊髄液管理の世界的シナリオにおいて最も急成長している市場です。この地域における脳脊髄液管理市場の成長は、高齢者人口の増加、先進医療機器への需要、効率的な治療を提供するヘルスケアインフラの増加に起因しています。

アジア太平洋地域の脳脊髄液管理市場の収益と2030年までの予測（US$Mn）

アジア太平洋地域の脳脊髄液管理市場のセグメンテーション

アジア太平洋地域の脳脊髄液管理市場は、製品、エンドユーザー、国に区分されます。

製品別では、アジア太平洋地域の脳脊髄液管理市場はCSFシャントとCSFドレナージシステムに二分されます。2022年にはCSFシャントセグメントがより大きな市場シェアを占めています。

エンドユーザー別に見ると、アジア太平洋地域の脳脊髄液管理市場は病院、クリニック、外来手術センター、その他に区分されます。病院セグメントが2022年に最大の市場シェアを占めました。

国別に見ると、アジア太平洋地域の脳脊髄液管理市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。中国が2022年のアジア太平洋地域脳脊髄液管理市場シェアを独占しました。

B.Braun SE、Integra LifeSciences Holdings Corp、Medtronic Plc、Natus Medical Inc、Spiegelberg GmbH &Co KGは、アジア太平洋地域の脳脊髄液管理市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋地域の脳脊髄液管理市場情勢

  • アジア太平洋地域のPEST分析

第5章 アジア太平洋地域の脳脊髄液管理市場-主要産業力学

  • 市場促進要因
    • 脳脊髄液漏出症例の増加
    • 脳脊髄液に関連する課題増加に対する政府の取り組み
  • 市場抑制要因
    • 故障や誤作動のリスク
  • 市場機会
    • 神経疾患治療における髄液管理への注目の高まり
  • 今後の動向
    • スマート脳脊髄液シャントの開発
  • インパクト分析

第6章 脳脊髄液管理市場-アジア太平洋地域市場分析

  • アジア太平洋地域の脳脊髄液管理市場の収益、2022年～2030年

第7章 アジア太平洋地域の脳脊髄液管理市場 - 収益と2030年までの予測：製品別

  • 市場収益シェア、2022年および2030年
  • 髄液シャント
  • 髄液ドレナージシステム

第8章 アジア太平洋地域の脳脊髄液管理市場 - 収益と2030年までの予測：エンドユーザー別

  • 市場収益シェア、2022年および2030年
  • 病院
  • 診療所
  • 外来手術センター
  • その他

第9章 アジア太平洋地域の脳脊髄液管理市場：国別分析

  • アジア太平洋地域の脳脊髄液管理市場：国別
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域

第10章 アジア太平洋地域の脳脊髄液管理市場：業界情勢

  • アジア太平洋地域脳脊髄液管理市場における成長戦略、2020年～2023年
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Medtronic Plc
  • Integra LifeSciences Holdings Corp
  • B. Braun SE
  • Natus Medical Inc
  • Spiegelberg GmbH & Co KG

第12章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Cerebrospinal Fluid Management Market Segmentation
  • Table 2. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 3. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 4. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 5. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 6. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 7. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 8. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 9. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 10. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 11. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 12. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 13. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 14. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 15. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 16. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 17. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 18. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 19. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 20. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 21. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 22. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 23. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 24. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 25. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 26. Recent Inorganic Growth Strategies in the Asia Pacific Cerebrospinal Fluid Management Market
  • Table 27. Recent Organic Growth Strategies in The Asia Pacific Cerebrospinal Fluid Management Market
  • Table 28. Glossary of Terms, Asia Pacific Cerebrospinal Fluid Management Market

List Of Figures

  • Figure 1. Asia Pacific Cerebrospinal Fluid Management Market Segmentation, By Country
  • Figure 2. Asia Pacific - PEST Analysis
  • Figure 3. Asia Pacific Cerebrospinal Fluid Management Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Asia Pacific Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Asia Pacific Cerebrospinal Fluid Management Market Revenue, Country (US$ Mn), 2022 - 2030
  • Figure 7. Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. CSF Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Ventriculoperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Ventriculoatrial Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Ventriculopleural Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Lumboperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. CSF Drainage Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. External Ventricular Drainage (EVD) Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Lumbar Drainage (LD) Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 17. Hospitals: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Clinics: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Ambulatory Surgical Centers: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Asia Pacific Cerebrospinal Fluid Management Market, by Key Country- Revenue (2022) ($Mn)
  • Figure 22. Asia Pacific Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 23. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Growth Strategies in The Asia Pacific Cerebrospinal Fluid Management Market, 2020-2023
目次
Product Code: TIPRE00028018

The Asia Pacific cerebrospinal fluid management market was valued at US$ 389.53 million in 2022 and is expected to reach US$ 613.54 million by 2030; it is estimated to grow at a CAGR of 5.8% from 2022 to 2030.

Increasing Focus on CSF Management in Neurological Disease Treatments Fuels the Asia Pacific Cerebrospinal Fluid Management Market

CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson's Disease (PD), Alzheimer's Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer's disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer's disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.

Asia Pacific Cerebrospinal Fluid Management Market Overview

The Asia Pacific cerebrospinal fluid management is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Asia Pacific is the fastest-growing market for cerebrospinal fluid management in global scenario. The cerebrospinal fluid management market growth in this region is attributed to growing geriatric population, demand for advanced medical devices, and increasing healthcare infrastructures offering efficient treatments.

Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)

Asia Pacific Cerebrospinal Fluid Management Market Segmentation

The Asia Pacific cerebrospinal fluid management market is segmented into product, end user and country.

Based on product, the Asia Pacific cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.

Based on end user, the Asia Pacific cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Asia Pacific cerebrospinal fluid management market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific cerebrospinal fluid management market share in 2022.

B. Braun SE, Integra LifeSciences Holdings Corp, Medtronic Plc, Natus Medical Inc, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the Asia Pacific cerebrospinal fluid management market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Cerebrospinal Fluid Management Market Landscape

  • 4.1 Overview
  • 4.2 Asia Pacific PEST Analysis

5. Asia Pacific Cerebrospinal Fluid Management Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
    • 5.1.2 Government Initiatives for Addressing Growing Challenges Associated with CSF
  • 5.2 Market Restraints
    • 5.2.1 Risk of Failure and Malfunctioning
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
  • 5.4 Future Trends
    • 5.4.1 Development of Smart Cerebrospinal Fluid Shunts
  • 5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - Asia Pacific Market Analysis

  • 6.1 Asia Pacific Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 CSF Shunts
    • 7.3.1 Overview
    • 7.3.2 CSF Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Ventriculoperitoneal Shunts
      • 7.3.3.1 Overview
      • 7.3.3.2 Ventriculoperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Ventriculoatrial Shunts
      • 7.3.4.1 Overview
      • 7.3.4.2 Ventriculoatrial Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Ventriculopleural Shunts
      • 7.3.5.1 Overview
      • 7.3.5.2 Ventriculopleural Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Lumboperitoneal Shunts
      • 7.3.6.1 Overview
      • 7.3.6.2 Lumboperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 CSF Drainage Systems
    • 7.4.1 Overview
    • 7.4.2 CSF Drainage Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 External Ventricular Drainage (EVD) Systems
      • 7.4.3.1 Overview
      • 7.4.3.2 External Ventricular Drainage (EVD) Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Lumbar Drainage (LD) Systems
      • 7.4.4.1 Overview
      • 7.4.4.2 Lumbar Drainage (LD) Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinics
    • 8.4.1 Overview
    • 8.4.2 Clinics: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Ambulatory Surgical Centers
    • 8.5.1 Overview
    • 8.5.2 Ambulatory Surgical Centers: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Cerebrospinal Fluid Management Market - Country Analysis

  • 9.1 Overview
      • 9.1.1.1 Asia Pacific Cerebrospinal Fluid Management Market, by Country
      • 9.1.1.2 China
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 China: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.2.3.1 China: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.2.3.2 China: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.2.4 China: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.3 Japan
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.3.3.1 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.3.3.2 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.3.4 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.4 India
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.4.3 India: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.4.3.1 India: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.4.3.2 India: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.4.4 India: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.5 Australia
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.5.3 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.5.3.1 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.5.3.2 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.5.4 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.6 South Korea
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.6.3 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.6.3.1 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.6.3.2 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.6.4 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.7 Rest of Asia Pacific
        • 9.1.1.7.1 Overview
        • 9.1.1.7.2 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.7.3 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.7.3.1 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.7.3.2 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.7.4 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by End User

10. Asia Pacific Cerebrospinal Fluid Management Market -Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in The Asia Pacific Cerebrospinal Fluid Management Market, 2020-2023
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Integra LifeSciences Holdings Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 B. Braun SE
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Natus Medical Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Spiegelberg GmbH & Co KG
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms